The joint resolution to roll back the regulator’s 2024 merger rule now heads to the president for a signature.

Regeneron Pharmaceuticals said it will acquire substantially all of 23andMe's assets for $256 million after coming out on top at a bankruptcy auction for the once-sizzling DNA-testing startup.

Memphis musician Billy Earheart was a founding member of the Amazing Rhythm Aces and worked with artists from B.B. King to ...

Memphis area residents can enjoy a variety of activities during Memorial Day weekend. Events include live music, historic exhibits, sporting events, and family-friendly activities. The weekend's ...

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

Pritzker’s 8 Stocks with Huge Upside Potential. In this article, we are going to take a look at where Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) stands against Nicholas J. Pritzker’s other ...

Judy D receives the signature makeup look of a particular ... and Apple and Piled Into a Popular Pharmaceutical Stock Up 395% Over the Last 5 Years ...

For the past seven years, Kat has been helping people make the best financial decisions for their unique situations, whether they're looking for the right insurance policies or trying to pay down ...

Reserve your free spot now. In March, MIRA Pharmaceuticals signed a binding letter of intent (LOI) to acquire SKNY Pharmaceuticals. Under the terms, MIRA will acquire SKNY through a stock ...

In this article, we are going to take a look at where Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands against Billionaire Ray Dalio’s Bridgewater’s other stock picks with huge upside potential.

Alvotech expects that potential U.S. tariffs on imported pharmaceuticals should have minimal impact on the Company's product revenues in 2025. Alvotech manufactures its biosimilars in Iceland, a ...

In trading on Tuesday, shares of Vertex Pharmaceuticals, Inc. (Symbol: VRTX) entered into oversold territory, hitting an RSI reading of 28.4, after changing hands as low as $431.65 per share.